In this conversation with The DHC Group's Mark Bard, Craig Romanok, Chief Commercial Officer at Digitas Health/Publicis Health, reflects on three decades of change in pharma marketing and the trends shaping its future. From the rise of health consumers to the promise of AI, Craig discusses why creativity continues to drive meaningful impact and why a multi-dimensional approach to AI will define tomorrow's industry leaders.

Operations leader joins agency to strengthen delivery excellence, scale collaboration, and advance connected ways of working across Digitas Health.  

At Cannes Lions, “Culture as Care: Embedding Health Where It Lives” challenged brands to stop waiting for patients and start showing up in everyday life. With perspectives from Novartis, Pinterest, and Digitas Health, the panel made one thing clear: when health aligns with culture, it becomes more relevant, engaging, and impactful.

Attending ASCO 2026 underscored both the meaningful progress in gynecologic cancer care and the urgent need for greater awareness. For many women in mid-life, menopause symptoms can mirror early warning signs of cancer—often leading to delayed diagnoses in the absence of reliable screening options.

A powerful look at how silence, stigma, and unspoken family history have shaped hereditary ovarian cancer—and how InHERitance is changing the conversation through storytelling, advocacy, and prevention.

A perspective from Adobe Summit 2026 on how AI is reshaping healthcare marketing—not by replacing agencies, but by eliminating outdated, inefficient processes. While fears around job loss and shrinking budgets are real, the true shift is toward scalable, personalized engagement that improves patient outcomes. Human creativity and strategy remain essential, with AI acting as the engine that enables more meaningful, timely connections at scale.